HLA-C and neoplasm: The first mechanism, already known to play an important role in inducing tumour immunogenicity,70 is through the release of tumour antigens and molecules collectively known as the “damage associated molecular pattern” (DAMPs),71,72 which can activate CD8+ cytotoxic T cells via the major histocompatibility complex (MHC) class I loading pathway.